Literature DB >> 31822945

Letter to the Editor: Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

Gang Xu1, Xiao-Xiang Zhou1, Wei-Yu Xu2, Yi-Lei Mao3.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 31822945     DOI： 10.1007/s00268-019-05318-y

Source DB:  PubMed          Journal:  World J Surg        ISSN： 0364-2313            Impact factor:   3.352


× No keyword cloud information.
  5 in total

1.  Propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group.

Authors:  R B D'Agostino
Journal:  Stat Med       Date:  1998-10-15       Impact factor: 2.373

2.  Short- and Long-Term Outcomes of Liver Resection for Intrahepatic Cholangiocarcinoma Associated with the Metabolic Syndrome.

Authors:  Christian Hobeika; François Cauchy; Nicolas Poté; Pierre-Emmanuel Rautou; François Durand; Olivier Farges; Safi Dokmak; Valérie Vilgrain; Maxime Ronot; Valérie Paradis; Olivier Soubrane
Journal:  World J Surg       Date:  2019-08       Impact factor: 3.352

3.  Non-alcoholic fatty liver disease, non-alcoholic steatohepatitis, metabolic syndrome and hepatocellular carcinoma-a composite scenario.

Authors:  Luca Viganò; Ana Lleo; Alessio Aghemo
Journal:  Hepatobiliary Surg Nutr       Date:  2018-04       Impact factor: 7.293

Review 4.  Treatment and Prognosis for Patients With Intrahepatic Cholangiocarcinoma: Systematic Review and Meta-analysis.

Authors:  Michael N Mavros; Konstantinos P Economopoulos; Vangelis G Alexiou; Timothy M Pawlik
Journal:  JAMA Surg       Date:  2014-06       Impact factor: 14.766

Review 5.  Physiological and biochemical basis of clinical liver function tests: a review.

Authors:  Lisette T Hoekstra; Wilmar de Graaf; Geert A A Nibourg; Michal Heger; Roelof J Bennink; Bruno Stieger; Thomas M van Gulik
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.